Barbara Ann Karmanos Cancer Institute

This study tests a new drug combination for people with aggressive types of lymphoma that haven't been treated yet. The treatment adds a targeted drug called polatuzumab vedotin to standard chemotherapy. The goal is to see if this combo can make the cancer disappear completely an…